Skip Navigation


European Heart Journal Advance Access originally published online on October 25, 2008
European Heart Journal 2008 29(24):3065; doi:10.1093/eurheartj/ehn472
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/24/3065    most recent
ehn472v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pastor-Pérez, F. J.
Right arrow Articles by Lip, G. Y.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pastor-Pérez, F. J.
Right arrow Articles by Lip, G. Y.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Is thrombogenesis related to residual platelet function in ischaemic heart disease?

Francisco J. Pastor-Pérez

Department of Cardiology
Hospital Universitario Virgen de la Arrixaca
Murcia 30120
Spain
Tel: +34 968369445
Fax: +34 968369662
Email: fcomarino@hotmail.com

Francisco Marín

Department of Cardiology
Hospital Universitario Virgen de la Arrixaca
Murcia
Spain

Sergio Manzano-Fernández

Department of Cardiology
Hospital Universitario Virgen de la Arrixaca
Murcia
Spain

Gregory Y.H. Lip

Haemostasis, Thrombosis and Vascular Biology Unit
University Department of Medicine
City Hospital
Birmingham
UK

The first 10% of the full text of this article appears below.

We read with great interest the recent study by Yano et al., 1 which reported that patients after percutaneous coronary intervention exhibit increased thrombogenicity in spite of dual antiplatelet therapy. This prothrombotic state is not related to residual platelet aggregability and seems to be determined mainly by the presence of co-morbidities, such as obesity, sleep . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?